- Nuheara (NUH) is preparing for the first shipment of its HP Hearing PRO hearing aid products to the US by the end of February
- NUH began the mass production of its hearing aid after the US FDA established a new category of over-the-counter hearing aids for mild to moderate hearing impairments
- Managing Director Justin Miller says the hearing aid market responded “very positively” to the launch of HP Hearing PRO last month at CES 2023 in Las Vegas
- As such, Mr Miller says the company has been acting on this interest and is looking to expand its US retail footprint
- Shares in Nuheara are up 7.69 per cent to 21 cents at 10:44 am AEDT
Nuheara (NUH) is poised for the first shipment of its HP Hearing PRO hearing aid products to the US before the end of February.
The company began the mass production of its hearing aid after the US Food and Drug Administration (FDA) established a new category of over-the-counter hearing aids for mild to moderate hearing impairments.
Nuheara Co-founder and Managing Director Justin Miller said the company was “incredibly excited” to have entered mass production and for the imminent first shipment.
“Having built a strong back-order book of sales, we are looking forward to seeing our hearing aids on US retail shelves and growing revenues,” Mr Miller said.
The OTC hearing aid category in the US covers 38 million people, and Mr Miller said retailers and other healthcare providers in the market had responded “very positively” to the company’s launch of the HP Hearing PRO last month at CES 2023 in Las Vegas.
“With first shipment about to occur, we have been busily acting on this interest and look forward to providing further updates on the expansion of our US retail footprint,” Mr Miller said.
Shares in Nuheara were up 7.69 per cent to 21 cents at 10:44 am AEDT.